Biomarkers in Alzheimer’s Disease

By Tapan Khan


Biomarkers in Alzheimer’s Disease provides a comprehensive overview of all modalities of Alzheimer’s disease biomarkers, including neuroimaging, cerebrospinal fluid, genomic, and peripheral systems. Each chapter integrates molecular/cellular abnormality due to Alzheimer’s disease and technological advancement of biomarkers techniques.

The book is ideal for clinical neuroscience and molecular/cellular neuroscience researchers, psychiatrists, and allied healthcare practitioners involved in the diagnosis and management of patients with cognitive impairment and Alzheimer’s disease, and for differential diagnosis of Alzheimer’s disease with other non-Alzheimer’s dementia.

  • Presents a comprehensive overview detailing all modalities of Alzheimer’s disease biomarkers
  • Written for neuroscience researchers and clinicians studying or treating patients with Alzheimer’s Disease
  • Integrates, in each chapter, the molecular/cellular abnormality due to Alzheimer’s disease and the technological advancement of biomarkers techniques

Product Details


Elsevier Science
Publication date:
Product dimensions:
7.70(w) x 9.30(h) x 0.70(d)


This content is for gold members only. Log In or Register to see
Tags: ,

Comments are closed.